Recently in 2021-2022, several research reports highlighted plitidepsin, a small cyclic peptide previously isolated from the tunicate Aplidium albicans and originally approved as anticancer to disclose very promising in vitro antiviral activity against SARS-CoV-2 with IC90 = 0.88 nM and might be a strong drug candidate that gives a hope for future treating of COVID-19 .